TS 033
Alternative Names: SGL 0010; TS-033Latest Information Update: 09 Oct 2008
At a glance
- Originator Taisho Pharmaceutical
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Sodium-glucose transport protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 02 Oct 2008 Discontinued - Phase-II for Type-1 diabetes mellitus (PO)
- 02 Oct 2008 Discontinued - Phase-II for Type-1 diabetes mellitus in Japan (PO)
- 02 Oct 2008 Discontinued - Phase-II for Type-2 diabetes mellitus (PO)